
Dec 18 (Reuters) - Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two late-stage studies.
More than half the plaque psoriasis patients across the studies showed clear or almost clear skin after 16 weeks of treatment with the once-daily drug, zasocitinib, the company said.
Takeda plans to file marketing applications with the U.S. Food and Drug Administration and other regulatory authorities in 2026.
If approved, zasocitinib would join a crowded plaque psoriasis market featuring well-established oral rivals like Bristol Myers' Sotyktu and Amgen's Otezla, plus injectables including Johnson & Johnson's Tremfya, AbbVie's Skyrizi, and Novartis' Cosentyx.
Takeda's pill offers a convenient daily pill alternative alongside Sotyktu and Otezla in a market dominated by injectable drugs for treating plaque psoriasis, in which red, scaly patches occur on the skin due to an overactive immune system.
The company is banking on the blockbuster potential of zasocitinib to help fill a revenue gap it faces after its inflammatory bowel disease drug Entyvio loses key patents at the end of the decade.
Takeda in January had said it expects zasocitinib, if approved, to generate peak annual sales in the range of $3 billion to $6 billion.
The drugmaker acquired zasocitinib from drug developer Nimbus Therapeutics in 2022 in a deal worth up to $6 billion. Nimbus had identified the compound with the help of AI, a trend picking up pace in the pharmaceutical industry as companies seek to accelerate development of medicines.
The drug was generally well tolerated and outperformed placebo and Amgen's Otezla, with treatment responses strengthening through week 24.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
IDF says up to 90% of Iran’s weapons industry could be hit within days - 2
African Forests Have Become a Source of Carbon Emissions - 3
Coffee Prices Finish Higher on Brazil Cop Concerns - 4
Warship sunk by British fleet, remains of sailor found after 225 years - 5
What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
Working out at the airport? Some fliers can already smell the sweat.
Party Urban areas of the World
'Pluribus' release date: Everything you need to know about the new series from 'Better Call Saul's' co-creator
Picking the Right Home Machines: A Commonsense Aide
Rediscovering Experience Through Excursions: Individual Travel Stories
'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
Vote in favor of your #1 sort of juice
Whale stranded off Germany for days found stuck again
Coca-Cola Co. and bottlers to invest in South Africa operations













